For comments, suggestions
Created with Raphaël 2.1.0 21.10.2016 Filing date 12.02.2021 Validation fee payment 30.04.2021 (A1) Patent application published 19.07.2022 AGEPI application filing date 30.09.2022 (T2) Translation of the validated European patent 16.05.2025 21.10.2025 Valid until 22.10.2026 Renewal fee to be paid until 21.10.2036 Patent will expire on

Patent in force


(210)Number of the EPO application20164728
(220)Filing date of the EPO application2016.10.21
(80)EPO patent specification publication (B)EPB nr. 17/2022, 2022.04.27
(110)EPO patent number3718565
(11)Number of the documentMD 3718565 T2
(21)Number of the applicatione 2021 0275
(71)Name(s) of applicant(s), code of the countryModernaTX, Inc., US;
(72)Name(s) of inventor(s), code of the countryCIARAMELLA Giuseppe, US;
HIMANSU Sunny, US;
(73)Name(s) of owner(s), code of the countryModernaTX, Inc., US;
(54)Title of the inventionRespiratory virus vaccines
(13)Kind-of-document code T2
(51)International Patent Classification A61K 39/12 (2006.01.01); A61P 11/00 (2006.01.01); C07K 16/10 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2021.04.30
(49)Date of publication of the translation of the validated European patent specification2022.09.30
(30)Priority201562245031 P, 2015.10.22, US; 201562244813 P, 2015.10.22, US; 201562244946 P, 2015.10.22, US; 201562244802 P, 2015.10.22, US; 201562244837 P, 2015.10.22, US; 201562247362 P, 2015.10.28, US; 201562247483 P, 2015.10.28, US; 201562247394 P, 2015.10.28, US; 201562247297 P, 2015.10.28, US
(74)Patent attorney(Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova
Up
/Inventions/details/3718565